July 12, 2010 - Avandia Controversy May Change FDA Response To Drug-Safety Concerns.

The Wall Street Journal (7/12, Mundy) reports that the controversy surrounding Avandia may even change the way the agency responds to safety concerns surrounding medications, especially those that it has already approved. The Journal quotes former FDA Commissioner David Kessler as calling the Avandia safety discussions "a defining moment" for both Commissioner Hamburg and Deputy Commissioner Sharfstein.